# OneMedNet Corp > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/OneMedNet Corp). ## Overview OneMedNet Corp is a U.S.-based commercial research services company focused on collecting, curating, and delivering medical imaging and related clinical data for research and analytics use. The company operates as a data-enabled services business serving healthcare, life sciences, and other research-oriented customers that need access to de-identified real-world medical data. ## Products & services • Medical imaging data collection and curation • De-identified clinical data access for research • Data licensing and research support services • Real-world evidence data sets for analytics - **Medical imaging data services** (45%) — Collection, organization, and delivery of imaging data for research and analytics use. - **Clinical data curation** (30%) — De-identification and structuring of clinical records and related metadata. - **Data licensing** (15%) — Licensing curated datasets to customers for research, model development, and analysis. - **Research support services** (10%) — Project support, data preparation, and related services for research workflows. - Medical imaging data collection and curation - De-identified clinical data access for research - Data licensing and research support services - Real-world evidence data sets for analytics ## Customers OneMedNet’s customers are typically organizations that need high-quality medical data for research, analytics, and product development. These buyers include life sciences companies, healthcare technology firms, and research institutions that value curated, de-identified datasets and the ability to use them in regulated workflows. - **Life sciences companies** (primary) — Buy curated medical data and research support for evidence generation and development programs. - **Healthcare technology companies** (primary) — Use de-identified imaging and clinical data to train, validate, and commercialize analytics tools. - **Research institutions** (secondary) — Purchase or access datasets for academic, translational, and clinical research projects. - **Healthcare providers and networks** (secondary) — May contribute data or engage for research-oriented data services and collaborations. - Life sciences companies using data for research and evidence generation - Healthcare technology firms building analytics and AI applications - Research institutions needing curated medical datasets - Clinical and commercial teams seeking real-world evidence inputs ## Geography OneMedNet is headquartered in the United States and its business is centered on U.S. healthcare data and research markets. Its operating footprint is tied to access to clinical data sources, healthcare providers, and research customers, so regulatory and data-governance requirements in the U.S. are central to the business. - Headquartered in the United States - Primary market is U.S. healthcare and research data - Operations depend on access to domestic clinical data sources - Regulatory and privacy rules shape where data can be collected and used ## Strategy The company’s strategy is to expand the utility of its medical data platform by increasing the volume, quality, and usability of curated datasets. It also depends on building customer relationships in research and analytics markets where differentiated data access can support recurring demand and broader use cases. - **Grow the curated data asset base** (medium-term) — More and better data increases the platform’s value to research customers. - **Deepen customer adoption in research markets** (medium-term) — Repeat usage and broader customer penetration support commercialization. - **Maintain compliance and data governance** (short-term) — Healthcare data businesses depend on privacy, consent, and regulatory trust. - Expand the supply of curated medical imaging and clinical data - Improve dataset quality and usability for research customers - Broaden commercial adoption across life sciences and health tech - Strengthen data platform value through de-identification and curation ## Risks The business depends on access to regulated healthcare data, so privacy, consent, and data-governance failures could materially disrupt operations. It also faces commercialization risk because demand depends on customers’ willingness to adopt curated datasets and on the company’s ability to maintain a differentiated data supply. - **Healthcare privacy and regulatory compliance** [high] — The company handles sensitive medical data and must meet privacy and de-identification requirements. - **Data supply concentration and access risk** [high] — The platform depends on continued access to clinical data sources and contributors. - **Commercial adoption risk** [medium] — Customers must see enough value in the datasets to renew or expand usage. - **Competition and substitution** [medium] — Other data vendors or internal customer data assets can reduce demand for the company’s offerings. - Healthcare privacy and data-use compliance risk - Dependence on access to clinical data sources - Customer adoption risk in research and analytics markets - Competition from alternative data providers and platforms ## Accounting For a data-services business like OneMedNet, revenue recognition depends on whether services are delivered over time or at a point in time, and on how licensing or subscription-like arrangements are structured. Investors should also watch estimates around collectability, contract assets, and any capitalization or impairment judgments tied to data platform development and intangible assets. - **Revenue recognition** — Can shift revenue between periods and affect comparability. - **Contract assets and receivables** — Affects working capital and credit-loss estimates. - **Intangible asset and software impairment** — Can create non-cash charges if expected cash flows weaken. - Revenue recognition for data services and licensing arrangements - Timing of delivery versus access-based service obligations - Allowance for doubtful accounts and collectability estimates - Capitalization and impairment of software or data-related assets --- *Last updated: 2026-04-29T04:43:57.603130+00:00*